Literature DB >> 10696437

Identification and characterization of glycoprotein H of MDV-1 GA strain.

P Wu1, W M Reed, S Yoshida, D Sui, L F Lee.   

Abstract

A 2439 bp open reading frame (ORF) was identified from the DNA sequence of BamHI-F and -K2 fragments of Marek's disease virus of serotype 1 (MDV-1) GA strain, which predicts an 813 amino acid polypeptide. This peptide is homologous to HSV-1 gH, and has typical glycoprotein features. There are nine potential N-linked glycosylation sites within the extracellular domain. A fragment of the gH ORF was cloned into pGEX vector in frame with glutathione S-transferase (GST) to produce a GST-gH fusion protein in Escherichia coli. The GST-gH fusion protein was used to develop gH monoclonal and polyclonal antibodies. Expression of gH was detected in duck embryo fibroblasts (DEFs) infected with MDV-1 GA strain by immunofluorescence assay (IFA) with these antibodies. Virus neutralization and plaque-forming inhibition analyses were conducted with the gH antiserum. There were no neutralization and plaque-forming inhibition activities of gH antiserum. Comparison of the DNA sequence of gH gene between GA and RB1B strains of MDV-1 revealed major difference in the upstream control elements of gH ORF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10696437

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  4 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells.

Authors:  D Schumacher; B K Tischer; S M Reddy; N Osterrieder
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  A New Strategy for Efficient Screening and Identification of Monoclonal Antibodies against Oncogenic Avian Herpesvirus Utilizing CRISPR/Cas9-Based Gene-Editing Technology.

Authors:  Man Teng; Zi-Yu Zhou; Yongxiu Yao; Venugopal Nair; Gai-Ping Zhang; Jun Luo
Journal:  Viruses       Date:  2022-09-14       Impact factor: 5.818

4.  Interaction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functions.

Authors:  Xiao-Jing Chi; Yi-Xin Lu; Peng Zhao; Chuan-Gen Li; Xiao-Jia Wang; Ming Wang
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.